Chemotherapy for Thymic Tumors: Induction, Consolidation, Palliation

Thoracic Surgery Clinics

Volumn 21, Issue 1, 2011, Pages 107-114

  Rajan, Arun ^a   Giaccone, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Thymic carcinoma; Thymoma

Indexed keywords

BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 12; METHYLPREDNISOLONE; PACLITAXEL; PREDNISONE; VINCRISTINE;

ALOPECIA; ANEMIA; ANOREXIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONSTIPATION; DECREASED APPETITE; DIARRHEA; DRUG FATALITY; FATIGUE; FEBRILE NEUTROPENIA; HAND FOOT SYNDROME; HUMAN; HYPERBILIRUBINEMIA; INFECTION; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; MYASTHENIA GRAVIS; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SIDE EFFECT; SKIN EXFOLIATION; STOMATITIS; THROMBOCYTOPENIA; THYMOMA; THYMUS SURGERY; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXORUBICIN; FLUOROURACIL; HUMANS; METHOTREXATE; NEOADJUVANT THERAPY; PALLIATIVE CARE; PROCARBAZINE; THYMOMA; THYMUS NEOPLASMS; VINCRISTINE;

EID: 78149421753     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2010.08.003     Document Type: Review

References (29)

1. Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003, 76(3):878-884. [discussion: 884-5].
2. Wright C.D., Choi N.C., Wain J.C., et al. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 2008, 85(2):385-389.
3. Ishikawa Y., Matsuguma H., Nakahara R., et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009, 88(3):952-957.
4. Yokoi K., Matsuguma H., Nakahara R., et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2007, 2(1):73-78.
5. Lucchi M., Melfi F., Dini P., et al. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 2006, 1(4):308-313.
6. Bretti S., Berruti A., Loddo C., et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer 2004, 44(1):69-77.
7. Shin D.M., Walsh G.L., Komaki R., et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998, 129(2):100-104.
8. Venuta F., Rendina E.A., Pescarmona E.O., et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997, 64(6):1585-1591. [discussion: 1591-2].
9. Kunitoh H., Tamura T., Shibata T., et al. A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan clinical oncology group trial (JCOG 9606). Br J Cancer 2010, 103(1):6-11.
10. Macchiarini P., Chella A., Ducci F., et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991, 68(4):706-713.
11. Berruti A., Borasio P., Gerbino A., et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 1999, 81(5):841-845.
12. Kim E.S., Putnam J.B., Komaki R., et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004, 44(3):369-379.
13. Jacot W., Quantin X., Valette S., et al. Multimodality treatment program in invasive thymic epithelial tumor. Am J Clin Oncol 2005, 28(1):5-7.
14. Rea F., Sartori F., Loy M., et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993, 106(3):543-549.
15. Bonomi P.D., Finkelstein D., Aisner S., et al. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993, 16(4):342-345.
16. Highley M.S., Underhill C.R., Parnis F.X., et al. Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999, 17(9):2737-2744.
17. Loehrer P.J., Yiannoutsos C.T., Dropcho S., et al. A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma [meeting abstracts 7079]. J Clin Oncol 2006, 24(Suppl 18).
18. Umemura S., Segawa Y., Fujiwara K., et al. A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy. Jpn J Clin Oncol 2002, 32(7):262-265.
19. Oguri T., Achiwa H., Kato D., et al. Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma. Chemotherapy 2004, 50(6):279-282.
20. Chahinian A.P., Bhardwaj S., Meyer R.J., et al. Treatment of invasive or metastatic thymoma: report of eleven cases. Cancer 1981, 47(7):1752-1761.
21. Loehrer P.J., Kim K., Aisner S.C., et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994, 12(6):1164-1168.
22. Loehrer P.J., Chen M., Kim K., et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997, 15(9):3093-3099.
23. Fornasiero A., Daniele O., Ghiotto C., et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991, 68(1):30-33.
24. Giaccone G., Ardizzoni A., Kirkpatrick A., et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer. Lung Cancer Cooperative Group. J Clin Oncol 1996, 14(3):814-820.
25. Loehrer P.J., Jiroutek M., Aisner S., et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001, 91(11):2010-2015.
26. Gordon M.S., Battiato L.A., Gonin R., et al. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. J Immunother Emphasis Tumor Immunol 1995, 18(3):179-184.
27. Igawa S., Murakami H., Takahashi T., et al. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer 2010, 67(2):194-197.
28. Palmieri G., Merola G., Federico P., et al. Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol 2010, 21(6):1168-1172.
29. Kunitoh H., Tamura T., Shibata T., et al. A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605). Br J Cancer 2009, 101(9):1549-1554.